Topics

Vertex Reports First-Quarter 2019 Financial Results

16:01 EDT 30 Apr 2019 | Businesswire
This article has expired, however you can still download the PDF.
Preview:
- First-quarter 2019 product revenues of $857 million, a 34% increase compared to $638 million in 2018- - First-quarter 2019 GAAP operating income increased 115% to $277 million; non-GAAP operating income increased 81% ...

Other Sources for this Article

Vertex Contacts:
Investors:
Michael Partridge, 617-341-6108
or
Eric Rojas, 617-961-7205
or
Zach Barber, 617-341-6470

Media:
617-341-6992
mediainfo@vrtx.com

NEXT ARTICLE

More From BioPortfolio on "Vertex Reports First-Quarter 2019 Financial Results"

Quick Search

Relevant Topics

BioPortfolio - life science, medical devices and pharmaceutical conference
BioPortfolio is a leading news, information and knowledge resource covering the global life science industries impacted on by biotechnology. The site aims to provide the lay person, the researcher and the management executive with a single location to so...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...